PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMABINDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY

被引：0
|
作者：
Irving, P. [1 ]
Sebastian, S. [1 ]
Probert, C. [1 ]
Gaya, D. [1 ]
Hamlin, P. J. [1 ]
Gillespie, G. [1 ]
Tate, H. [1 ]
Wheeler, C. [1 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
来源：
GUT | 2017年 / 66卷
关键词：
D O I：
10.1136/gutjnl-2017-314127.21
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
21
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [1] PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY
    Irving, P.
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2016, 65 : A87 - A87
  • [2] Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
    Irving, P.
    Probert, C.
    Gaya, D. R.
    Hamlin, P. J.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S250 - S251
  • [3] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2017, 66 : A8 - A8
  • [4] GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS: PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS FROM THE GO-COLITIS STUDY
    Sebastian, S.
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2017, 66 : A122 - A123
  • [5] Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
    Probert, C.
    Gaya, D. R.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S57 - S58
  • [6] Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
    Probert, Christopher S. J.
    Sebastian, Shaji
    Gaya, Daniel R.
    Hamlin, P. John
    Gillespie, Gillian
    Rose, Anita
    Tate, Helen
    Wheeler, Colin
    Irving, Peter M.
    Probert, C.
    Gaya, D.
    Sebastian, S.
    Hart, A.
    Irving, P.
    Ahmad, T.
    Pollok, R.
    Orchard, T.
    Arasaradnam, R.
    Iqbal, T.
    Johnson, M.
    Kaser, A.
    Allen, P.
    Gordon, J.
    Preston, C.
    Shenderey, R.
    Hoque, S.
    Bloom, S.
    Ansari, A.
    Mowat, C.
    Hamlin, J.
    Arnott, I
    Shaw, I
    Steed, H.
    Butterworth, J.
    Robinson, A.
    Mawdsley, J.
    Creed, T.
    Cummings, F.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
  • [7] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GOCOLITIS STUDY
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2016, 65 : A2 - A3
  • [8] The Association Between Disease Activity and Patient-Reported Outcomes in Patients With Moderate-to-Severe Ulcerative Colitis in the United States
    DiBonaventura, Marco
    Bargo, Danielle
    Lucas, James
    Bluff, Daniel
    Hoskin, Ben
    Salese, Leonardo
    Cappelleri, Joseph C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S352 - S352
  • [9] Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
    Jharap, B.
    Sandborn, W. J.
    Reinisch, W.
    D'Haens, G.
    Robinson, A. M.
    Wang, W.
    Huang, B.
    Lazar, A.
    Thakkar, R. B.
    Colombel, J. -F.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (09) : 1082 - 1092
  • [10] The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe
    Alessandro Armuzzi
    Miriam Tarallo
    James Lucas
    Daniel Bluff
    Benjamin Hoskin
    Danielle Bargo
    Joseph C. Cappelleri
    Leonardo Salese
    Marco daCosta DiBonaventura
    [J]. BMC Gastroenterology, 20
12345